Companies / Croatia
Barr Closes Pliva Deal
October 2006 | Company News AlertUS firm Barr Laboratories has essentially closed its US$2.5bn purchase of Croatian firm Pliva, to exploit the expanding Eastern European generics market. The combination of the two companies creates the world's third largest generics operation behind Switzerland's Sandoz and Israel's Teva Pharmaceutical Industries. It is BMI's view that further consolidation among generic manufacturers is likely as competition in the sector
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
